§ Funding Round
Series B funding round for Affinia Therapeutics raising $110M in May 2021
Series B funding round for Affinia Therapeutics raising $110M in May 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Angel | ed mathers | |
New Enterprise Associates | — | — |
| Organization | — | |
| Organization | — | |
caroline stoutLEAD | Angel | caroline stout |
| Organization | — | |
F-Prime Capital | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
TCGX | — | — |
| Organization | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$210M
Top Valuation
-
Affinia Therapeutics raised $110M in a Series B round.
The round was announced on 05/01/21.
The round was led by caroline stout, Farallon Capital Management.
